Antihypertensive Therapy for Elderly Women with Hypertension

Primary First-Line Recommendation

The American Heart Association recommends thiazide diuretics, particularly chlorthalidone, as the optimal first-line choice for treating hypertension in elderly women, with dihydropyridine calcium channel blockers as an equally appropriate alternative 1
Low-dose thiazide diuretics are the accepted first-line treatment for elderly patients with hypertension, with robust evidence supporting this recommendation 2
Chlorthalidone demonstrated superiority over lisinopril in preventing stroke and over amlodipine in preventing heart failure in older hypertensive patients in the ALLHAT trial 1
Thiazide diuretics have been shown to reduce cardiovascular morbidity and mortality in elderly patients, including those with isolated systolic hypertension 2, 3

Dihydropyridine calcium channel blockers, particularly amlodipine, are equally effective as first-line therapy and may be preferred if thiazides are not tolerated 1
Calcium channel blockers are as effective as diuretics for reducing all cardiovascular events except heart failure, where thiazides show superiority 1
Amlodipine 2.5-5 mg daily is appropriate for elderly patients, with lower initial doses recommended due to decreased clearance and increased drug exposure in this population 4

Beta-blockers are not recommended as first-line therapy in elderly patients unless specific comorbidities exist, such as coronary artery disease or heart failure 4, 1
ACE inhibitors or ARBs are reasonable alternatives but were less effective than thiazide diuretics in preventing stroke and less effective than CCBs in preventing heart failure in head-to-head trials 1

The European Society of Cardiology recommends starting with monotherapy, with thiazide diuretic or dihydropyridine CCB as first choice, and titrating gradually over 4 weeks 3, 1
The American College of Cardiology recommends adding a second agent if target blood pressure is not achieved, with effective combinations including ACE inhibitor/ARB + CCB, ACE inhibitor/ARB + thiazide diuretic, or CCB + thiazide diuretic 1, 2

The European Heart Journal recommends a target blood pressure of <140/90 mmHg for elderly patients, with consideration of <130/80 mmHg if well tolerated 5, 3
The American Heart Association recommends continuing or initiating treatment in patients aged ≥80 years, starting with monotherapy and adding a second drug if needed 5

The European Society of Cardiology recommends always measuring blood pressure in both sitting and standing positions in elderly patients to assess for orthostatic hypotension 5, 3
The American College of Cardiology recommends monitoring for electrolyte abnormalities, particularly hypokalemia with thiazide therapy, and following up within 2-4 weeks after medication initiation or dose changes to assess efficacy and adverse effects 1, 3

The European Heart Journal recommends avoiding rapid dose escalation in elderly patients, as this increases the risk of adverse effects including orthostatic hypotension and falls 5, 3
The American Heart Association recommends not discontinuing effective and well-tolerated therapy when a patient reaches age 80, and not ignoring standing blood pressure measurements 5, 3
The American College of Cardiology recommends not using beta-blockers as first-line therapy unless the patient has coronary artery disease or heart failure as compelling indications 4, 1